FREE OZEMPIC LAWSUIT EVALUATION — No Fees Unless You Win 1-800-555-0000
Lawsuit Timeline & Updates

Ozempic Lawsuit Timeline:
2026 Updates
& Settlement Forecast

Reviewed by: ClaimCheckUSA Legal TeamLast updated: March 26, 2026Reading time: 7 min

Ozempic Lawsuit Timeline

1
2017Ozempic FDA Approval

Novo Nordisk receives FDA approval for Ozempic (semaglutide) for type 2 diabetes management.

2
2021Wegovy Approved for Weight Loss

FDA approves Wegovy (higher-dose semaglutide) for chronic weight management, dramatically expanding the patient population.

3
2022First Lawsuits Filed

Early plaintiffs begin filing individual lawsuits alleging gastroparesis and other severe GI injuries caused by Ozempic and Wegovy.

4
Aug 2023JAMA Study Published

A landmark JAMA study finds GLP-1 users face 9.09× higher risk of gastroparesis, 4.22× higher risk of bowel obstruction, and 3.67× higher risk of pancreatitis compared to non-users.

5
Sep 2023FDA Anaesthesia Warning

FDA issues safety communication warning that retained gastric contents in GLP-1 patients pose aspiration risk during anaesthesia and sedation procedures.

6
Feb 2024MDL Established

The Judicial Panel on Multidistrict Litigation consolidates all federal Ozempic/Wegovy lawsuits into MDL No. 3094 in the Eastern District of Pennsylvania before Judge Gene Pratter.

7
2024Bellwether Selection

The MDL court begins the process of selecting bellwether (test) cases to go to trial first, which will set the tone for global settlement negotiations.

8
2025Discovery Phase

Extensive document discovery from Novo Nordisk and Eli Lilly. Internal communications, clinical trial data, and regulatory correspondence are reviewed.

9
2026Settlement Negotiations Begin

With bellwether trials approaching, settlement negotiations are expected to intensify. Global settlement discussions are anticipated in late 2026 or 2027.

10
2027 (est.)Global Settlement Expected

Based on comparable mass tort timelines (Roundup, talc, opioids), a global settlement is anticipated in 2027–2028. Individual payouts are expected to range from $100,000 to $500,000+.

Don't Wait — File Your Claim Now

Cases filed earlier receive priority in settlement distributions. Check your eligibility in 60 seconds. No fees unless you win.

Check My Eligibility

Frequently Asked Questions

When will the Ozempic lawsuit settle?
Based on comparable mass tort timelines, a global settlement is anticipated in 2027–2028. The MDL is currently in the discovery and bellwether selection phase. Settlement negotiations typically intensify once bellwether trial results are known, as they provide a roadmap for valuing individual claims.
How long will it take to receive my Ozempic settlement payment?
After a global settlement is reached, individual claims typically take 6–18 months to process and pay out. The total timeline from filing to payment is typically 3–5 years for mass tort cases. Cases filed earlier generally receive priority in the settlement process.
Is it too late to join the Ozempic lawsuit?
As of 2026, it is not too late for most victims. The statute of limitations is typically 2–3 years from when you knew or should have known your injury was caused by the drug. However, you should consult an attorney immediately — waiting reduces the strength of your claim and risks missing the deadline.
What is an MDL and how does it affect my case?
An MDL (Multidistrict Litigation) consolidates similar federal lawsuits before one judge for efficient pretrial proceedings. Your individual case retains its identity but benefits from shared discovery and bellwether trials. If no global settlement is reached, your case can be returned to your home district for trial.
What are bellwether trials and why do they matter?
Bellwether trials are a small number of representative cases tried first in an MDL. Their outcomes — verdicts and settlement amounts — provide a benchmark for valuing all other claims and typically trigger global settlement negotiations. A large plaintiff verdict in a bellwether trial significantly increases settlement values for all claimants.